At AACR 2024 Learn How Pepper Tackles ‘Undruggable’ Targets: ML-Driven Transomics Identifies Four Leading Candidates to Treat HCC

April 5-10, San Diego Pepper Bio is on a mission to decipher the root causes of diseases and identify effective treatments—thereby illuminating the fastest, safest path to drug discovery. COMPASS, our ML-driven platform, is built on the world's first and largest proprietary transomics database, integrating genomic, transcriptomic, proteomic, and phosphoproteomic data. Our approach offers a comprehensive understanding of biological systems based not just on expression but also on the activity…

Comments Off on At AACR 2024 Learn How Pepper Tackles ‘Undruggable’ Targets: ML-Driven Transomics Identifies Four Leading Candidates to Treat HCC

See Pepper Bio’s 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases

Pepper Bio landed $6.5 million in seed funding led by NFX. The startup wants to improve the drug-discovery process for pharma companies using AI. Pepper Bio is also developing treatments itself and expects to begin clinical trials next year. Drug discovery is expensive and time-consuming for pharmaceutical and biotech companies. From identifying the right biological targets implicated in a disease, to developing drugs that impact those targets through years-long clinical…

Comments Off on See Pepper Bio’s 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases

Pepper Bio hopes to challenge Eroom’s law with new funding

Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn’t getting cheaper. Some hope that AI can help, and it likely will — when it comes to biotech, it is much more than a buzzword.  But Boston-based drug discovery…

Comments Off on Pepper Bio hopes to challenge Eroom’s law with new funding

Overcoming EGFRi Resistance Through Transomic Analyses

Pepper Bio is on a mission to put an end to untreatable diseases by enabling more effective drug discovery through the use of transomic analysis. We do this using our COMPASS platform that integrates data across the genomic, transcriptomic, proteomic, and phosphoproteomic biological layers to uncover global, functional and causal understanding of complex biological processes. At the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference, hosted by the American Association…

Comments Off on Overcoming EGFRi Resistance Through Transomic Analyses

Podcast: Unlocking the Potential of Transomics in Biotech

In this enlightening episode, the Artificial Intelligence podcast sat down with Samantha Dale Strasser, the co-founder and CSO of Pepper Bio, a pioneering company in the world of transomics drug discovery. Discover the vital role of phosphoproteomic data, the challenges and innovations in integrating multiple -omics layers, and how AI is set to revolutionize clinical trials and drug discovery. Join us on this journey as we explore the foundation of…

Comments Off on Podcast: Unlocking the Potential of Transomics in Biotech

Podcast: Using Transomics In Drug Discovery

Samantha Dale Strasser is the Chief Science Officer and co-founder of Pepper Bio. Pepper Bio is the world's first transomics analysis company. Transomics involves analyzing a wealth of biological information from genomics all the way up to more functional data of phosphoproteomics. Pepper Bio is able to see more relevant disease insights about how to best treat disease and how to characterize potential drugs that can be used as therapeutics.…

Comments Off on Podcast: Using Transomics In Drug Discovery